Results 231 to 240 of about 25,894 (252)

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Drug Discovery Today, 2022
Guo-Bo Li, Jun-Lin Yu
exaly  

Structure-based drug repositioning: Potential and limits

Seminars in Cancer Biology, 2021
Daniele Parisi, Melissa F Adasme, Michael Schroeder   +2 more
exaly  

Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives

Drug Discovery Today, 2022
Yan Zhang, Boshi Huang
exaly  

Signatures for drug repositioning

Nature Reviews Genetics, 2011
openaire   +2 more sources

COVID-19 drugs and drug repositioning

2021
Introduction: The COVID-19 pandemic is caused by SARS-CoV-2. Drug repositioning is a propitious field in the development and discovery of therapeutic agents that distinguishes new therapeutic options for existing drugs. There are repositioned drugs in COVID-19 treatment. Aim: We aimed to explore repositioned drugs for COVID-19 pharmacotherapy.
openaire   +1 more source

Drug repositioning: Progress and challenges in drug discovery for various diseases

European Journal of Medicinal Chemistry, 2022
Yadong Chen, Yanmin Zhang, Haichun Liu   +2 more
exaly  

Topological network measures for drug repositioning

Briefings in Bioinformatics, 2021
Thomas Sauter, Sébastien De Landtsheer, Apurva Badkas   +2 more
exaly  

HeTDR: Drug repositioning based on heterogeneous networks and text mining

Patterns, 2021
Xiangrong Liu, Zhangming Niu, Shuting Jin   +2 more
exaly  

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Briefings in Bioinformatics, 2021
Peng Wang, Yajie Meng, Cai Lijun
exaly  

Drug Repositioning

2017
openaire   +1 more source